Abstract:OBJECTIVE:To analyze the feasibility of using vascular plaque quantification (VPQ) to evaluate carotid atherosclerotic plaques and to observe the effect of statins on carotid atherosclerotic plaques. METHODS:Patients with carotid plaques from January 2016 to September 2018 in Peking University First Hospital Neurology Department were recruited and underwent three-dimonsional ultrasound (3DUS). Their gray scale median (GSM) and other parameters of carotid plaques were measured with VPQ. The patients were divided into low GSM group (GSM < 40) and high GSM group (GSM≥40). The clinical characteristics and plaque characteristics of the patients in the two groups were compared to analyze the stability of plaques. According to whether taking statins or not, the patients were further divided into statin group and non-statin group, plaque GSM and other parameters of their carotid plaques were measured and the changes of carotid plaques at the end of 3 months and 2 years were observed. RESULTS:A total of 120 patients were enrolled, including 79 males and 41 females, with an average age of (65.39±9.11) years. The patients were divided into low GSM group (31 cases) (GSM < 40) and high GSM group (89 cases) (GSM≥40). The stenosis of the lumen in the low GSM group was more severe (the area stenosis rate was 41.32%±21.37% vs. 29.79%±17.16%, P < 0.05). The nor-malized wall index (NWI) of plaque in low GSM group was significantly higher than that in high GSM group (0.61 ±0.14 vs. 0.52±0.12, P < 0.01). A total of 77 patients, including 51 males and 26 females, aged (64.96±9.58) years, were enrolled to observe the statin effects on carotid plaque. They were divided into statin group (n=56) and non-statin group (n=21) according to whether taking statins or not. At the baseline and 3-month follow-up, there were no significant differences in carotid plaque volume, area, degree of luminal stenosis and GSM between the two groups (P>0.05). At the end of the 2-year follow-up, GSM increased in the statin group [median 10.00 (2.00, 28.00)] but decreased in the non-statin group [median －7.00 (－11.00, 5.50)], with a statistically significant difference between the two groups (P < 0.01). There was no significant increase in carotid plaque volume in the statin group, while there was a slight increase in the non-statin group, but there was no significant difference between the two groups [median increase in plaque volume was 0.00 (－30.00, 40.00) mm3 in the statin group and 30.00 (10.00, 70.00) mm3 in the non-statin group, P>0.05]. CONCLUSION:The VPQ technology of 3DUS can be used to evaluate carotid atherosclerotic plaques. Patients with low GSM (GSM < 40) have more severe vascular stenosis and higher normalized wall index. VPQ technology can also be used to observe the effect of statins on carotid plaque, the GSM of plaques increase in patients who are taking moderate-intensity statin treatment for two years.

Three-dimensional Ultrasound Imaging: an Effective Method to Detect the Effect of Moderate Intensity Statin Treatment in Slowing Carotid Plaque Progression

Associations among Carotid Plaque Progression, Cerebrovascular/ Cardiovascular Diseases and LDL-C/non-HDL-C Goal Achievement in Diabetic Patients: A Retrospective Cohort Study

Evaluation of the effect of atorvastatin on neovascularization in the carotid atherosclerotic plaques by contrast enhanced ultrasonography

Effect of Lipitor on the Biomechanics of Carotid Atherosclerotic Plaques by Velocity Vecto Imaging

[Evaluation of Carotid Atherosclerotic Plaques by Vascular Plaque Quantification (VPQ) Technology of Three-Dimensional Ultrasonography].

Subclinical atherosclerosis evaluated by high resolution ultrasonography in patients with newly diagnosed type 2 diabetes mellitus un-dergoing intensive treatment

Atorvastatin Calcium for Carotid Atherosclerotic Plaques:Evaluation with Contrast-Enhanced Ultrasonography

Effect of Statin Therapy on the Progression of Common Carotid Artery Intima-Media Thickness: an Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

The value of three-dimensional ultrasound in evaluating carotid artery plaquevolume and predicting risk events in coronary heart disease patients

Application of High-Resolution MRI in Evaluating Statin Efficacy on Symptomatic Intracranial Atherosclerosis

Study on the assessment of carotid plaque stability by Ktrans of dynamic contrast material-enhanced magnetic resonance imaging in elderly patients treated with statin

Intravascular Ultrasonic Evaluation of the Effects of Statins on Atherosclerotic Plaque of Coronary Heart Disease with Mild Elevation of LDL-C

Abstract 5092: Effects of Intensive Lipid Therapy on Atherosclerotic Plaque Burden and Time-course: A Prospective, Randomized, Double Blinded Study With Magnetic Resonance Imaging (MRI)

Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis.

Longer Duration of Statin Therapy is Associated with Decreased Carotid Plaque Vascularity by Magnetic Resonance Imaging.

Validation of real-time three-dimensional ultrasonography for carotid atherosclerosis

Effect of statin therapy on the progression of coronary atherosclerosis

Fractal dimension based carotid plaque characterization from three-dimensional ultrasound images

Combining Ultrasound with Bio-Indicators Reveals Progression of Carotid Stenosis.

Comparative studies on the effects of different doses of atorvastatin combined with aspirin on inflammatory cytokines and carotid plaques in patients with ischemic cerebrovascular disease

Effects on simvastatin on the atherosclerotic plaques of carotid artery in elderly patients with normal lipidenia level